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Endolymphatic sac tumors are rare low malignant neoplasms of the petrous temporal 
bone, with symptoms referable to auditory, vestibular or facial nerves, which should be 
strictly discriminated from benign tumors of the temporal bone.  Differential diagno-
sis between both at the early stages of checkup controls the treatment and prognosis. 
Complete surgical resection is the treatment of choice, which commonly provides long-
term control.  We have experienced a 48-year-old man with progressive hearing loss, un-
steadiness and constant tinnitus.  Computed tomography and magnetic resonance imag-
ing (MRI) demonstrated a tumor invading the posterior petrous bone, extending to the 
posterior fossa.  In the course of image diagnosis of his disease, we observed diagnostic 
efficacy of 3-tesla MRI, which showed excellent lesion visualization even in a small-size 
endolymphatic sac tumor.  The intraoperative pathologic diagnosis was not available. 
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Endolymphatic sac tumors, rare lesions of the 
petrous temporal bone, arise in the vicinity of the 
inner ear but may extend to both the posterior fos-
sa and the middle ear.  In 1984, Hassard et al. pro-
posed that the endolymphatic sac could give rise 
to adenomatous papillary tumors (Hassard et al., 
1984).  Five years later, Heffner (1989) reviewed 
20 papillary-cystic temporal bone tumors, report-
ing the origin as the endolymphatic sac.  Despite 
a benign histopathologic appearance, these lesions 
are regarded clinically adenocarcinomas since 
then often are locally invasive.  Endolymphatic 
sac tumors frequently manifest sensorineural 
hearing loss, facial paralysis and disequilibrium. 
Upon imaging, they show significant dural in-
volvement. Light microscopic patterns may be 
follicular or papillary and solid. Both patterns 
often are mixed in the same tumor.  Magnetic 
resonance imaging (MRI) variegated lesion of the 
temporal bone; multiple foci of high signal inten-
sity indicate the hypervascular part of the tumor, 
scattered low-signal foci represent connective 
tissue scarring following bleeding.  We present a 
patient with endolymphatic sac tumor, describing 
clinical, imaging, intraoperative and pathologic 
features. 
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Patient Report
 
A 48-year-old man was admitted to Tottori Uni-
versity Hospital in 2005 because of right-sided 
sensorineural hearing loss accompanied by per-
sistent tinnitus.  He also had recurrent episodes 
of disequilibrium and mild headache.  Otologic 
examination was performed, including pure-tone 
audiometry, impedance testing and vestibular 
testing.  Audiometric data indicated complete 
hearing loss in the right-ear, with normal imped-
ance.  Caloric testing demonstrated no response 
to irrigation of the right external auditory canal. 
Otoscopic observations, facial nerve examination 
and findings concerning remaining cranial nerves 
were normal.  Systemic examination for von 
Hippel-Lindau disease was performed including 
brain and dorsal MRIs, whole body computed to-
mography (CT), ophthalmologic and also genetic 
examination (the deficit of 3p25-26) revealing all 
negative results.  CT of the temporal bone showed 
an osteolytic mass on the posteroinferior side of 
the petrous bone.  The mass extended to the dura 
of the posterior fossa and invaded the right inner 
ear.  On 3T MRI with gadolinium enhancement, 
the tumor showed heterogeneous signal intensity. 
Scattered low intensity areas appeared among 
multiple high-intensity foci in both T1- and T2-
weighted images (Figs. 1 and 2).  Angiography 
demonstrated a hypervascular lesion in the petrous 
bone supplied by the occipital and ascending pha-
ryngeal arteries.  Prior to surgery, these arteries 
were embolised (Fig. 3).  The patient underwent 
mastoidectomy, disclosing a hard mass between 
the posterior fossa and the lateral hemicanal.  The 
mass extended to the jugular bulb, internal audi-
tory canal, retrofacial space and infralabyrinthine 
air cells.  After exposing the sigmoid sinus by 
Fig. 1.  Radiological findings in the present patient. 
 A: Computed tomography (CT) scan of the temporal bone; 
 B: T1-weighted 3-tesla (3T) magnetic resonance imaging (MRI);
 C: T1-weighted 3T MRI after gadolinium administration;
 D: T2-weighted 3T MRI. 
The tumor arises along the right petrous ridge, producing bone erosion near the in-
ner ear.  Heterogenous signal intensity is seen by T1- and T2-weighted MRI (arrow).
A
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making a Bill’s island bone flap, the tumor was 
found to extend to the posterior fossa dura and 
also the middle fossa dura.  We then obtained 
tissue for intraoperative pathologic examination. 
The first 2 small specimens from the surface of 
the mass were not diagnostic of tumor, showing 
granulomatous reaction with fibrosis, hypervascu-
larity and cholesterol deposition.  As preoperative 
imaging showed a tumor, we submitted another 
specimen from a deeper, reddish portion of the 
mass, obtaining an intraoperative pathologic diag-
nosis of endolymphatic sac tumor.  The 3rd tumor 
was resected in a piece meal fashion, resulting in 
incomplete removal with a portion of the tumor 
tissue attached to the jugular bulb. 
 Postoperative pathologic examination of the 
resected tissue demonstrated cuboidal to high 
columnar atypical cells with round nuclei, a papil-
lary arrangement (Fig. 4) and an invasion of the 
bony structures.  Immunochemical study showed 
the tumor cells to be reactive for cytokeratin 
AE1/3, vimentin, epithelial membrane antigen and 
neuron-specific enolace, focally reactive for glial 
fibrillary acidic protein.  Tumor cells were nega-
tive for carcinoembryonic antigen, chromogranin, 
synaptophysin, cluster designation 34, cluster 
designation 117, carbohydrate antigen 19-9, S-100 
protein, anti lymphatic endothelium marker D2-
40 and Ki-67 (expression < 1%).
 On the 1st postoperative day, the patient had 
slight cerebrospinal fluid leakage from the thinned 
Fig. 2.  Typical images in the present patient using 1.5-tesla MRI (A: T1-weighted; B: T2-weighted).  Tumor visual-
ization is inferior to that with 3-tesla MRI. 
Fig. 3.  Right external carotid arteriogram demonstrates 
blood supply from the postauricular artery. 
Fig. 4.  Low-power photomicrograph of the resection 
specimen demonstrates a papillary growth pattern char-
acteristic of endolymphatic sac tumor (hematoxylin and 
eosin,  100). 
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area of the posterior fossa dura.  This complica-
tion was repaired under general anesthesia.  No 
other complications occurred. Stereotactic radio-
therapy with 65 Gy was administered after the 
repair surgery.  The patient has undergone regular 
follow-up for 30 months.  CT and MRI have de-
tected no residual tumor enlargement. 
 
 
Discussion
 
Endolymphatic sac tumors are rare tumors of the 
temporal bone, recently have been recognized as a 
distinct entity after previously having been classi-
fied with other papillary middle ear tumors (Gaffey 
et al., 1988, 1994; Li et al., 1993).  In 1989, Hef-
fner reviewed 20 papillary tumors of the temporal 
bone, concluding that all were low-grade adeno-
carcinomas likely to have originated from the en-
dolymphatic sac (Heffner, 1989).  Only 1 case had 
been reported prior to that, by Hassard et al. (1984), 
who definitively identified the tumor’s origin as 
the endolymphatic sac upon unexpectedly finding 
a mass during sac decompression surgery. 
 Chief clinical manifestations of endolym-
phatic sac tumors include sensorineural hearing 
loss, disequilibrium, facial nerve paralysis and 
palsies involving other nearby cranial nerves. 
Although complications of endolymphatic sac 
tumor vary with extent of tumor growth, the most 
consistent early symptom is sensorineural hearing 
loss.  Endolymphatic sac tumor is difficult to dif-
ferentiate from other lesions of the temporal bone 
and posterior fossa, typically being discovered at 
an advanced stage and lacking specific symptoms. 
In our patient an otologic examination indicated 
only a temporal bone lesion of unknown nature. 
CT, MRI and angiography were needed to de-
termine that a tumor was present and determine 
some of its characteristics.  CT imaging displayed 
a destructive lesion of the temporal bone involving 
the posterior aspect of the petrous pyramid, which 
lies mainly within the posterior part of the petrous 
bone.  MRI at 3T with gadolinium enhancement 
disclosed a heterogeneous lesion, while scattered 
low-intensity areas were admixed with multiple 
high-intensity foci on both T1- and T2-weighted 
images.  A portion of the dura showed gado-
linium enhancement indicating tumor invasion. 
Angiography depicted a hypervascular lesion in 
the petrous pyramid, supplied predominantly by 
a branch of the occipital artery.  The differential 
diagnosis included paraganglioma, endolymphatic 
sac tumor, metastasis from an occult primary can-
cers, chondrosarcoma and cholesterol granuloma. 
Paraganglioma and endolymphatic sac tumor 
were most likely based on tumor location, bone 
destruction, signal intensity patterns on MRI and 
the feeding artery.  Endolymphatic sac tumor is a 
locally aggressive malignant tumor and paragan-
glioma is a benign neoplasm, preoperative differ-
entiation between the 2 diagnoses was important 
for planning surgical approach for resection. Un-
fortunately, endolymphatic sac tumor could be di-
agnosed only intraoperatively.  Ricards and Clif-
ton (2003) reported that endolymphatic sac tumor 
was heterogeneous in signal intensity pattern, with 
heterogeneous gadolinium enhancement.  Multiple 
high-intensity foci on both T1 and T2-weighted 
images indicated the presence of methemaglobin, 
blood-filled or proteinaceous cysts and cholesterol 
clefts.  Mukherji et al. (1997) performed MRI in 
15 cases of endolymphatic sac tumor, noting that 
appearance varied with tumor size. Lesions 2 cm 
or less in diameter was heterogeneous, with a rim 
of increased signal on T1-weighted images.  Tu-
mors were enhanced with gadolinium administra-
tion.  Larger tumors showed intratumoral areas of 
increased signal on non-gadolinium T1-weighted 
images.  Patel et al. (2006) reviewed 31 cases 
of endolymphatic sac tumor and described T1-
weighted MRI post-gadolinium scans showed het-
erogeneous enhancement in all cases (100%).  T2-
weighted images showed heterogeneous signals in 
all lesions (100%).  Those authors proposed that 
signal characteristics could be used to differenti-
ate endolymphatic sac tumor from other lesions 
occurring in this region (Mukherji et al., 1997). 
Our patient’s tumor was 2 cm in diameter, making 
it comparable to the smaller tumors above.  How-
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ever, 3T MRI showed a heterogeneous pattern 
without a rim of increased signal in T1-weighted 
images without gadolinium.  Typical images com-
paring 3T MRI (Fig. 1) with 1.5-tesla MRI (Fig. 2) 
demonstrate a favorable higher signal-to-noise 
ratio using 3T MRI.  This modality may provide 
improved imaging for use with intraoperative 
navigation systems.
 Pathologically, endolymphatic sac tumors ap-
peared nonaggressive, but these tumors often are 
locally invasive (Luff et al., 2002).  Heffner (1989) 
reported endolymphatic sac tumor morphology as 
including complex arrays of interdigitating papil-
lary processes infiltrating surrounding tissue, em-
bedded in dense fibrous tissue showing evidence 
of past hemorrhage as well as cholesterol clefts 
and inflammatory cells.  The latter tumor charac-
teristics posed difficulties in intraoperative patho-
logic assessment, which were surmounted only 
by resecting the superficial part of the tumor and 
then submitting a specimen from the deep, hyper-
vascular part of the lesion.  Immunopathological 
findings of our patient were positive expression of 
cytokeratin AE1/3, vimentin, glial fibrillary acidic 
protein and negative of carcinoembryonic antigen, 
synaptophysin, carbohydrate antigen 19-9 and 
anti lymphatic endothelium marker D2-40. These 
results corresponded to the reports of Asano et al. 
(1999) and Rodrigues et al. (2004).  Their reports 
showed the activity of the endolymphatic sac tu-
mors related to the level of Ki-67 and the charac-
teristics of tumors were expression of glial fibril-
lary acidic protein and vimentin.  Fortunately, the 
level of Ki-67 was below 1% in our patient, delib-
erate long-term observation was necessary for the 
patient. 
 Ultimately, tumor removal was incomplete 
because dense connective tissue remaining in 
the operative field interfered with and precluded 
enbroc resection.  Devaney et al. (2003) reported 
that most patients with endolymphatic sac tumor 
were difficult to cure by surgical resection.  Treat-
ment options include embolisation followed by 
subtotal resection, as well as other strategies; 
nonetheless, surgical excision remains the main-
stay of therapy for endolymphatic sac tumor.  Ef-
ficacy of stereotactic radiotherapy is not known, 
but our patient underwent this treatment in view 
of subtotal resection (Heffner, 1989; Megerian 
et al., 1995; Hansen and Luxford, 2004).   Two 
previous reports described remote metastasis of 
endolymphatic sac tumor; Ferreira et al. (2002) 
and Robson et al. (1990).  In 2005, Bambakidis et 
al. reported the 1st case of metastasis to the spine 
(Bambakids, 2005).  Given the uncertainties, our 
patient will need careful follow-up connecting 
both local recurrence and metastasis. 
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